Tag: post-approval drug monitoring
Drug Safety Monitoring: How the FDA Tracks Generic Drugs After Approval
The FDA doesn't stop monitoring generic drugs after approval. Learn how FAERS, MedWatch, Sentinel, and inspections work together to catch hidden safety issues in the millions of generic prescriptions filled every day.
view morerecent posts
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis are rare but deadly drug reactions that cause skin and mucous membrane detachment. Learn the warning signs, triggers, and why genetic testing can save lives.
Published ON: 14 NovThe FDA doesn't stop monitoring generic drugs after approval. Learn how FAERS, MedWatch, Sentinel, and inspections work together to catch hidden safety issues in the millions of generic prescriptions filled every day.
Published ON: 19 NovEulexin (flutamide) was once a standard prostate cancer hormone therapy, but newer drugs like enzalutamide and apalutamide are now safer and more effective. Learn how they compare and why doctors are moving away from flutamide.
Published ON: 18 NovExplore how the EU's multi-track regulatory system for generic medicines affects drug availability, pricing, and competition across member states-with key updates from the 2025 Pharma Package reforms.
Published ON: 17 NovMost people who think they're allergic to penicillin aren't. Learn the difference between true allergies and common side effects-and why getting tested could save your life.
Published ON: 9 Nov